Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
PLoS One. 2013 Oct 4;8(10):e74848. doi: 10.1371/journal.pone.0074848. eCollection 2013.
Women of reproductive age in parts of sub-Saharan Africa are faced both with high levels of HIV and the threat of dying from the direct complications of pregnancy. Clinicians practicing in such settings have reported a high incidence of direct obstetric complications among HIV-infected women, but the evidence supporting this is unclear. The aim of this systematic review is to establish whether HIV-infected women are at increased risk of direct obstetric complications.
Studies comparing the frequency of obstetric haemorrhage, hypertensive disorders of pregnancy, dystocia and intrauterine infections in HIV-infected and uninfected women were identified. Summary estimates of the odds ratio (OR) for the association between HIV and each obstetric complication were calculated through meta-analyses. In total, 44 studies were included providing 66 data sets; 17 on haemorrhage, 19 on hypertensive disorders, five on dystocia and 25 on intrauterine infections. Meta-analysis of the OR from studies including vaginal deliveries indicated that HIV-infected women had over three times the risk of a puerperal sepsis compared with HIV-uninfected women [pooled OR: 3.43, 95% confidence interval (CI): 2.00-5.85]; this figure increased to nearly six amongst studies only including women who delivered by caesarean (pooled OR: 5.81, 95% CI: 2.42-13.97). For other obstetric complications the evidence was weak and inconsistent.
The higher risk of intrauterine infections in HIV-infected pregnant and postpartum women may require targeted strategies involving the prophylactic use of antibiotics during labour. However, as the huge excess of pregnancy-related mortality in HIV-infected women is unlikely to be due to a higher risk of direct obstetric complications, reducing this mortality will require non obstetric interventions involving access to ART in both pregnant and non-pregnant women.
在撒哈拉以南非洲部分地区,育龄妇女不仅面临着艾滋病毒感染率高的问题,而且还面临着因妊娠直接并发症而死亡的威胁。在这种环境下行医的临床医生报告称,艾滋病毒感染妇女中直接产科并发症的发生率很高,但支持这一报告的证据并不明确。本系统评价旨在确定艾滋病毒感染妇女是否面临更高的直接产科并发症风险。
本研究比较了感染和未感染艾滋病毒的妇女发生产科出血、妊娠高血压疾病、难产和宫内感染的频率。通过荟萃分析计算了艾滋病毒与每种产科并发症之间关联的比值比(OR)的汇总估计值。共有 44 项研究提供了 66 组数据,其中 17 项研究关于出血,19 项研究关于妊娠高血压疾病,5 项研究关于难产,25 项研究关于宫内感染。包括阴道分娩的研究中 OR 的荟萃分析表明,与未感染艾滋病毒的妇女相比,感染艾滋病毒的妇女产后脓毒症的风险高出三倍以上[汇总 OR:3.43,95%置信区间(CI):2.00-5.85];而仅包括剖宫产妇女的研究中这一数字增加到近六倍[汇总 OR:5.81,95%置信区间(CI):2.42-13.97]。对于其他产科并发症,证据较弱且不一致。
艾滋病毒感染孕妇和产后妇女宫内感染的风险较高,可能需要采取针对性策略,在分娩期间预防性使用抗生素。然而,由于艾滋病毒感染妇女妊娠相关死亡率的巨大增加不太可能是由于直接产科并发症的风险增加所致,因此降低这一死亡率需要采取非产科干预措施,包括为孕妇和非孕妇提供 ART。